Concerns around Pharmac's transparency, equity

Author
Newstalk ZB,
Publish Date
Thu, 2 Dec 2021, 5:35PM
PHARMAC is not likely to fund medication for rare diseases anytime soon (Getty Images)
PHARMAC is not likely to fund medication for rare diseases anytime soon (Getty Images)

Concerns around Pharmac's transparency, equity

Author
Newstalk ZB,
Publish Date
Thu, 2 Dec 2021, 5:35PM

Pharmac is potentially a good model, but there are issues. 

A panel reviewing the drug buying agency has released its interim report on its operation. 

Review chair Sue Chetwin says told Heather du Plessis-Allan Pharmac's under increasing challenges from consumers, patient advocates and clinicians.  

She said the big concerns are mostly the same from everyone.  

They’re all around access to medicine, the timing of medicines, the transparency of how Pharmac actually operates and, very importantly, equity issues.” 

A final report is due at the end of February, with recommendations. 

LISTEN ABOVE